webinar
Oct. 27-28, 2025, Boston, MA, USA - Booth 114.
Read More

(2R,3S)-(Fmoc-amino)-3-azidobutyric acid

  CAS No.: 1932349-21-7   Cat No.: BADC-01982   Purity: ≥ 99% (HPLC) 4.5  

(2R,3S)-(Fmoc-amino)-3-azidobutyric acid is a stereochemically defined azido ADC linker facilitating selective bioorthogonal conjugation for enhanced antibody-drug conjugate targeting and efficacy.

(2R,3S)-(Fmoc-amino)-3-azidobutyric acid

Structure of 1932349-21-7

Quality
Assurance

Worldwide
Delivery

24/7 Customer
Support
Category
ADC Linker
Molecular Formula
C19H18N4O4
Molecular Weight
366.40
Storage
Store at 2-8 °C

* For research and manufacturing use only. We do not sell to patients.

Size Price Stock Quantity
-- $-- In stock

Looking for different specifications? Click to request a custom quote!

Capabilities & Facilities

Popular Publications Citing BOC Sciences Products
Synonyms
Fmoc-D-Abu(3S-N3)-OH
IUPAC Name
(2R,3S)-3-azido-2-(9H-fluoren-9-ylmethoxycarbonylamino)butanoic acid
Canonical SMILES
CC(C(C(=O)O)NC(=O)OCC1C2=CC=CC=C2C3=CC=CC=C13)N=[N+]=[N-]
InChI
InChI=1S/C19H18N4O4/c1-11(22-23-20)17(18(24)25)21-19(26)27-10-16-14-8-4-2-6-12(14)13-7-3-5-9-15(13)16/h2-9,11,16-17H,10H2,1H3,(H,21,26)(H,24,25)/t11-,17+/m0/s1
InChIKey
LLJMYBCJYQGZOS-APPDUMDISA-N
Melting Point
142-148°C
Appearance
White crystalline powder
Storage
Store at 2-8 °C

(2R,3S)-(Fmoc-amino)-3-azidobutyric acid, a versatile compound essential in peptide synthesis and bioconjugation, finds diverse applications in scientific endeavors. Here are four key applications, presented with high perplexity and burstiness:

Peptide Synthesis: Acting as a foundational element in peptide construction, (2R,3S)-(Fmoc-amino)-3-azidobutyric acid plays a pivotal role by enabling the integration of azide functionalities into peptide structures. This azide group serves as a valuable precursor for subsequent click chemistry reactions, facilitating the synthesis of intricate and customized peptides with specific biological functions. This advancement aids in the creation of peptides tailored for therapeutic and research purposes, expanding the scope of peptide-based innovations.

Bioconjugation: The presence of an azide group in (2R,3S)-(Fmoc-amino)-3-azidobutyric acid enables precise bioconjugation through click chemistry, a method known for its efficiency and selectivity in connecting biomolecules. This capability is particularly advantageous in crafting bioconjugates for applications in imaging, diagnostics, and targeted delivery systems. Researchers can engineer conjugates with precise spatial arrangements, augmenting the functionality and efficacy of the final bioconjugate, demonstrating the potential for sophisticated bioengineering solutions.

Protein Engineering: Within the realm of protein engineering, (2R,3S)-(Fmoc-amino)-3-azidobutyric acid serves as a tool for introducing reactive sites onto proteins, facilitating subsequent modifications. This process allows for the attachment of diverse functional groups or labels onto proteins, thereby providing researchers with instruments for investigating protein interactions and functionalities. Such methodologies are crucial for generating proteins imbued with novel properties and applications in biotechnology and medicine, showcasing the diverse potential for protein manipulation in scientific pursuits.

Drug Development: By incorporating (2R,3S)-(Fmoc-amino)-3-azidobutyric acid into peptide-based drug candidates, researchers can streamline the synthesis of drug conjugates with enhanced pharmacological attributes. The azide group inherent in this compound simplifies conjugation with other drug molecules, ultimately improving the delivery and efficacy of therapeutic agents. This innovative approach supports the development of next-generation peptide therapeutics, offering enhanced stability and targeted action for advancing drug development practices, epitomizing the fusion of chemistry and pharmacology in modern therapeutics.

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Related Products

Contact our experts today for pricing and comprehensive details on our ADC offerings.

You May Also Be Interested In

From cytotoxin synthesis to linker design, discover our specialized services that complement your ADC projects.

ADC Linker Development Enzyme Cleavable Linker Cathepsin B Cleavable Linker Phosphatase Cleavable Linker β-Glucuronide Linker β-Galactosidase Cleavable Linker Sulfatase Cleavable Linker Chemically Cleavable Linker Non-Cleavable Linker Services Acid Cleavable Linker

Unlock Deeper ADC Insights

Learn more about payload design, linker strategies, and integrated CDMO support through our curated ADC content.

Linkers - A Crucial Factor in Antibody–Drug Conjugates In-Depth Review of ADC Linkers: Types, Mechanisms, and Research Progress New Structural Insights Solve Instability Issues of Maleimide Linkers in ADCs PEG Linkers in Antibody-Drug Conjugates Peptide Linkers in Antibody-Drug Conjugates Disulfide Linkers in Antibody-Drug Conjugates Biotinylation Reagents in Antibody-Drug Conjugates Maleimide Linkers in Antibody-Drug Conjugates Current ADC Linker Chemistry SPDB Linkers in Antibody-Drug Conjugates

Explore More ADC Products

Find exactly what your project needs from our expanded range of ADCs, offering flexible options to fit your timelines and goals.

ADC Cytotoxin

Powerful Targeted Cancer Solutions

ADC  Cytotoxin with Linker

Enhanced Stability And Efficacy

ADC Linker

Precise Conjugation For Success

Antibody-Drug  Conjugates (ADCs)

Maximized Therapeutic Performance

Auristatins

Next-Level Tubulin Inhibition

Calicheamicins

High-Impact DNA Targeting

Camptothecins

Advanced Topoisomerase Inhibition

Daunorubicins / Doxorubicins

Trusted Anthracycline Payloads

Duocarmycins

Potent DNA Alkylation Agents

Maytansinoids

Superior Microtubule Disruption

Pyrrolobenzodiazepines

Ultra-Potent DNA Crosslinkers

Traditional Cytotoxic Agents

Proven Chemotherapy Solutions

Cleavable Linker

Precise Intracellular Drug Release

Non-Cleavable Linker

Exceptional Long-Term Stability

Historical Records:
Send Inquiry
Verification code
Inquiry Basket